Bottom Line: A near-solo-developed Early Access sleeper that turns the grind of building a drug empire into one of the most compulsive management loops on Steam — rough edges and all, it's the rare crime sim that respects your time and your greed in equal measure.
The Gameplay Loop
The loop is the whole game, and it's magnificent. You start with almost nothing: a product, a customer, and your own two feet. Early hours are deliberately menial — you're the grower, the chemist, the courier, and the salesperson, sprinting across Hyland Point to meet buyers before their interest cools. It's tactile and slightly stressful, and it teaches you the systems by making you be every part of them.
Then the pivot happens. You rent a second property. You set up a grow room that doesn't need your constant babysitting. You hire your first employee, and suddenly a task you were doing by hand runs on its own. This is where Schedule I reveals its actual genre: it's an automation game wearing a crime thriller's coat. The dopamine isn't in the dealing. It's in watching a machine you built handle the dealing for you, then reinvesting the surplus into a bigger machine.
What elevates it above the glut of idle-adjacent management sims is that automation is never free and never total. Every layer you delegate introduces new friction — supply bottlenecks, employee logistics, police heat that scales with your footprint, rivals sniffing at your margins. You're constantly trading one problem for a larger, more interesting one. Progression here is a series of graduations, each unlocking a fresh category of headache to optimize away.
Systems Depth & Emergence
The recipe and refinement system deserves specific praise. Tuning potency isn't a slider; it's an investment decision with downstream consequences for pricing, demand, and the kind of customers you attract. Layer that against property upgrades, supply-chain management, and money laundering, and you get genuine emergent complexity — decisions that ripple. Do you push potency and chase premium buyers, or scale volume and flood the low end? The game doesn't answer for you.
Where It Strains
Honesty demands the caveats, and they're the textbook Early Access ones. The late-game economy loses tension. Once your operation is humming and automated, the challenge curve flattens into grind — you're waiting on numbers more than making decisions. The balance between active engagement and idle income isn't fully solved, and the endgame can feel like busywork padding out a loop that already delivered its best hours earlier. Content variety, while growing monthly, still thins out once you've seen the core systems. These aren't design failures so much as an unfinished game showing its seams — but you should know they're there before the sixty-hour mark.
Onboarding
The early-game-as-tutorial approach mostly works, teaching by doing rather than by wall-of-text. But the onboarding friction is real: some systems, particularly recipe optimization and employee assignment, reveal their rules through trial and error more than clear signposting. Patient players will find that satisfying. Impatient ones will bounce off the first grind wall before the automation payoff justifies it.